Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

Clinical trial NCT01522833 · COMPLETED

Trial details

NCT number: NCT01522833
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2012-10-01
Primary completion: 2015-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.